Switch theme
Sign up to access all valuation multiples
Chase Science Co Ltd operates as an electronic payment information technology solution provider. The company's products are to provide merchants and banks with software and hardware products and services related to electronic payment.
1995
n/a
Last FY Revenue $29.2M
Last FY EBITDA $8.5M
$815M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Chase Science Co achieved revenue of $29.2M and an EBITDA of $8.5M.
Chase Science Co expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Chase Science Co valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $29.2M | XXX | XXX | XXX |
| Gross Profit | XXX | $15.0M | XXX | XXX | XXX |
| Gross Margin | XXX | 51% | XXX | XXX | XXX |
| EBITDA | XXX | $8.5M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 29% | XXX | XXX | XXX |
| EBIT | XXX | $1.9M | XXX | XXX | XXX |
| EBIT Margin | XXX | 6% | XXX | XXX | XXX |
| Net Profit | XXX | $7.7M | XXX | XXX | XXX |
| Net Margin | XXX | 27% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of August 18, 2025, Chase Science Co's stock price is CNY 29 (or $4).
Chase Science Co has current market cap of CNY 6.0B (or $829M), and EV of CNY 5.9B (or $815M).
See Chase Science Co trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $815M | $829M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of August 18, 2025, Chase Science Co has market cap of $829M and EV of $815M.
Chase Science Co's trades at 28.0x EV/Revenue multiple, and 95.7x EV/EBITDA.
Equity research analysts estimate Chase Science Co's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Chase Science Co's P/E ratio is not available.
See valuation multiples for Chase Science Co and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $829M | XXX | $829M | XXX | XXX | XXX |
| EV (current) | $815M | XXX | $815M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 28.0x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 95.7x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 438.5x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | 107.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 395.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialChase Science Co's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Chase Science Co's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Chase Science Co's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Chase Science Co and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 45% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Adyen | XXX | XXX | XXX | XXX | XXX | XXX |
| Tyro Payments | XXX | XXX | XXX | XXX | XXX | XXX |
| Keyware Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| eFinance | XXX | XXX | XXX | XXX | XXX | XXX |
| Yeahka | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Chase Science Co acquired XXX companies to date.
Last acquisition by Chase Science Co was XXXXXXXX, XXXXX XXXXX XXXXXX . Chase Science Co acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Chase Science Co founded? | Chase Science Co was founded in 1995. |
| Where is Chase Science Co headquartered? | Chase Science Co is headquartered in China. |
| Is Chase Science Co publicy listed? | Yes, Chase Science Co is a public company listed on SHE. |
| What is the stock symbol of Chase Science Co? | Chase Science Co trades under 300941 ticker. |
| When did Chase Science Co go public? | Chase Science Co went public in 2021. |
| Who are competitors of Chase Science Co? | Similar companies to Chase Science Co include e.g. Adyen, Tyro Payments, Keyware Technologies, eFinance. |
| What is the current market cap of Chase Science Co? | Chase Science Co's current market cap is $829M |
| Is Chase Science Co profitable? | Yes, Chase Science Co is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
